Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial-Reference-Cited by-同舟云学术

Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

Published:2017-11-27 Issue:3 Volume:14 Page:596-608
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Sesay Sanie¹,Brzostek Jerzy²,Meyer Ingo³,Donazzolo Yves⁴,Leroux-Roels Geert⁵,Rouzier Régine⁶,Astruc Béatrice⁷,Szymanski Henryk⁸,Toursarkissian Nicole⁹,Vandermeulen Corinne¹⁰,Kowalska Edyta¹¹,Van Damme Pierre¹²,Salamand Camille¹,Pepin Stephanie¹

Affiliation:

1. Sanofi Pasteur, Marcy l'Etoile, France

2. Clinic of Infectious Diseases Health Care Team, Dębica, Poland

3. CRS Clinical Research Services Kiel GmbH, Lübeck, Germany

4. Eurofins-Optimed, Gières, France

5. Center for Vaccinology, Ghent University and University Hospital, Gent, Belgium

6. Centre CAP, Centre Médical Odysseum, Montpellier, France

7. Biotrial, Rennes Cedex, France

8. St Hedwig of Silesia Hospital, Department of Paediatrics, Prusicka, Trzebnica, Poland

9. Medic Trials, Berlin, Germany

10. Leuven University Vaccinology Center, Leuven, Belgium

11. “Medyk”, Wola, Poland

12. Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, Antwerpen (Wilrijk), Belgium

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2017.1384106

Reference33 articles.

1. Multiple Genotypes of Influenza B Virus Circulated between 1979 and 2003

2. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983

3. National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2014–2015. Ottawa, Canada: Public Health Agency of Canada;2014 [accessed 2016 Aug 29]. http://www.phac-aspc.gc.ca/naci-ccni/flu-grippe-eng.php.

4. The rationale for quadrivalent influenza vaccines

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of locally produced trivalent inactivated influenza vaccine (Tri Fluvac) in healthy Thai adults aged 18–64 years in Nakhon Phanom: A Phase III double blinded, three-arm, randomized, controlled trial;Vaccine;2024-01

2. Estimated health and economic impact of using high-dose influenza vaccine on respiratory and circulatory plus respiratory hospitalizations of older adults in Australia;Vaccine: X;2023-12

3. Sex differences in adverse events following seasonal influenza vaccines: a meta-analysis of randomised controlled trials;Journal of Epidemiology and Community Health;2023-09-21

4. Quadrivalent Vaccines for the Immunization of Adults against Influenza: A Systematic Review of Randomized Controlled Trials;International Journal of Environmental Research and Public Health;2022-08-01

5. Immunogenicity and safety levels of inactivated quadrivalent influenza vaccine in healthy adults via meta-analysis;Human Vaccines & Immunotherapeutics;2021-06-22